← back to search

Alexander J. Keeley

Sheffield Health and Social Care NHS Foundation Trust · GB
Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Streptococcal Infections and Treatments, SARS-CoV-2 detection and testing, and Neonatal and Maternal Infections.
h-index
24
citations
10,148
works
75
NIH funding
primary concept
Medicine
email

Recent publications

Prevalence and risk factors for Staphylococcus aureus colonisation among healthy individuals in low- and middle-income countries: A systematic review and meta-analysis
Journal of Infection 2025cited by 18position: middledoi
Evaluating clinical decision rules and rapid diagnostic tests for the diagnosis of Streptococcus pyogenes pharyngitis in Gambian children: A diagnostic accuracy study
Journal of Infection 2025cited by 3position: middledoi
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting
Nature Medicine 2025cited by 2position: firstdoi
Household Molecular Epidemiology of <i>Streptococcus pyogenes</i> Carriage and Infection in The Gambia
The Journal of Infectious Diseases 2025cited by 1position: middledoi
Streptococcus pyogenes carriage and infection within households in The Gambia: a longitudinal cohort study
The Lancet Microbe 2024cited by 13position: middledoi
Development and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human sera
Journal of Immunological Methods 2024cited by 8position: middledoi
Molecular Methods Enhance the Detection of Pyoderma-Related <i>Streptococcus pyogenes</i> and <i>emm</i> -Type Distribution in Children
The Journal of Infectious Diseases 2024cited by 5position: middledoi
A flow cytometry-based assay to determine the ability of anti-Streptococcus pyogenes antibodies to mediate monocytic phagocytosis in human sera
Journal of Immunological Methods 2024cited by 4position: middledoi
Characterization of an IL-8 cleavage inhibition assay to determine the functionality of anti-SpyCEP antibodies in human sera
Journal of Immunological Methods 2024cited by 3position: middledoi
Health-seeking behaviour and beliefs around sore throat in The Gambia: A qualitative study
PLOS Global Public Health 2024cited by 3position: middledoi
<i>Streptococcus pyogenes</i> Colonization in Children Aged 24–59 Months in the Gambia: Impact of Live Attenuated Influenza Vaccine and Associated Serological Responses
The Journal of Infectious Diseases 2023cited by 16position: firstdoi
Streptococcus pyogenes carriage acquisition, persistence and transmission dynamics within households in The Gambia (SpyCATS): protocol for a longitudinal household cohort study
Wellcome Open Research 2023cited by 8position: middledoi
Streptococcus pyogenes carriage acquisition, persistence and transmission dynamics within households in The Gambia (SpyCATS): protocol for a longitudinal household cohort study
Wellcome Open Research 2023cited by 2position: middledoi
Characterising within-hospital SARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves
Nature Communications 2022cited by 87position: middledoi
Genomic Characterization of Skin and Soft Tissue Streptococcus pyogenes Isolates from a Low-Income and a High-Income Setting
mSphere 2022cited by 24position: middledoi
Development and Characterisation of a Four-Plex Assay to Measure Streptococcus pyogenes Antigen-Specific IgG in Human Sera
Methods and Protocols 2022cited by 10position: firstdoi
Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial
BMC Infectious Diseases 2022cited by 9position: middledoi
Publisher Correction: Characterising within-hospital SARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves
Nature Communications 2022cited by 3position: middledoi
Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level
Pathogens and Immunity 2021cited by 67position: middledoi
Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data
eLife 2021cited by 39position: middledoi
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Cell 2020cited by 4,468position: middledoi
Complications of miliary tuberculosis: low mortality and predictive biomarkers from a UK cohort
BMC Infectious Diseases 2017cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thushan I. de Silva · University of London14 papers (2021–2025)Michael Marks · University of Oxford7 papers (2022–2025)Edwin P. Armitage · London School of Hygiene & Tropical Medicine7 papers (2022–2025) · 7 papers (2022–2025) · 5 papers (2022–2024) · 5 papers (2023–2025) · 5 papers (2022–2024)Beate Kampmann · Harvard University4 papers (2022–2023)Danilo Gomes Moriel · University of Queensland4 papers (2022–2024)Pierre R. Smeesters · London School of Hygiene & Tropical Medicine4 papers (2022–2025)Abdul Karim Sesay · MRC Unit the Gambia4 papers (2022–2023) · 3 papers (2023–2024) · 3 papers (2022–2024)Adam J. Kucharski · University of London3 papers (2023–2025) · 3 papers (2024–2024) · 3 papers (2023–2024) · 3 papers (2023–2025)Saffiatou Darboe · MRC Unit the Gambia3 papers (2022–2025)Isatou Ceesay · London School of Hygiene & Tropical Medicine3 papers (2023–2024)Francesco Berlanda Scorza · Seattle University3 papers (2024–2024)